Formulatrix ٣١ يوليو ٢٠٢٤ Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics - News-Medical
Formulatrix ١٩ ديسمبر ٢٠٢٣ Exploring instruments for assay development and optimization - News-Medical
Formulatrix ١٦ نوفمبر ٢٠٢٣ Simplifying Assay Development and Optimization while Minimizing Costs - News-Medical
Formulatrix ١١ يناير ٢٠١٩ FORMULATRIX® digital PCR technology to be acquired by QIAGEN - the-scientist.com